価格表

在庫・価格 : 2026年04月23日 11時52分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Galectin-1, Human, Goat-Poly
データシート
AF1152 RSDアールアンドディー システムズ
R&D Systems, Inc.
100 μg ¥83,000 1個 追加

在庫・価格 : 2026年04月23日 11時52分 現在

Anti-Galectin-1, Human, Goat-Poly

  • 商品コード:AF1152
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥83,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Okamoto H et al. Comparative proteomic profiles of meningioma subtypes. Cancer Res. 2006 Oct;66(20):10199-204
Okamoto H et al
2006/01/01
Species: Human, Application: Western Blot, Sample type: Homogenized Tissue PubMed
2 Zhuo Y et al. Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J. Biol. Chem. 2008 Aug;283(32):22177-85
Zhuo Y et al
2008/01/01
Species: Human, Application: Western Blot, Cell Lysates PubMed
3 Cimmino F et al. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness. Oncogene 2009 May;28(19):2015-23
Cimmino F et al
2009/01/01
Application: IHC Paraffin-embedded,Western Blot, Sample Type: Cell Lysates,Whole Tissue PubMed
4 Gieseke F et al. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 2010 Nov;116(19):3770-9
Gieseke F et al
2010/01/01
Application: ELISA Development, Sample Type: Cell Supernates PubMed
5 Zhao XY et al. Synergistic induction of galectin-1 by CCAAT/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells. J. Biol. Chem. 2011 Oct;286(42):36808-19
Zhao XY et al
2011/01/01
Application: ELISA Development, Sample Type: Cell Supernates PubMed
6 Suzuki O et al. Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells. Lab. Invest. 2012 Feb;92(2):191-9
Suzuki O et al
2012/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
7 Ryu KH et al. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury. Exp. Cell Res. 2014 Aug;326(1):143-54
Ryu KH et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Leskela S et al. Graves' disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells. PLoS ONE 2015;10(4):e0123938
Leskela S et al
2015/01/01
Application: Flow Cytometry,IHC Frozen, Sample Type: Whole Cells,Whole Tissue PubMed
9 Yazawa EM et al. Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential. J. Invest. Dermatol. 2015 Jul;135(7):1849-62
Yazawa EM et al
2015/01/01
Application: Flow Cytometry,Western Blot, Sample Type: Tissue Homogenates,Whole Cells PubMed
10 Unverdorben L et al. Prototype and Chimera-Type Galectins in Placentas with Spontaneous and Recurrent Miscarriages. Int J Mol Sci 2016 Apr;17(5)
Unverdorben L et al
2016/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
11 Andersen MN et al. Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation. Onco Targets Ther 2017;10:1977-1982
Andersen MN et al
2017/01/01
Application: ELISA Capture, Sample Type: Serum PubMed
12 Paz H et al. Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008. J. Exp. Clin. Cancer Res. 2018 Mar;37(1):67
Paz H et al
2018/01/01
Species: Human, Applications: Flow PubMed
13 Schulz H et al. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. Int J Mol Sci 2017 Jun;18(6)
Schulz H et al
2017/01/01
PubMed
14 Hirose I et al. Glucocorticoid receptor inhibits Müller glial galectin-1 expression via DUSP1-dependent and -independent deactivation of AP-1 signalling. J Cell Mol Med 2019 10;23(10):6785-6796
Hirose I et al
2019/01/01
PubMed
15 Chung LY et al. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res 2012 Aug;18(15):4037-47
Chung LY et al
2012/01/01
Species: Human, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Okamoto H et al. Comparative proteomic profiles of meningioma subtypes. Cancer Res. 2006 Oct;66(20):10199-204
    Okamoto H et al
    2006/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Zhuo Y et al. Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J. Biol. Chem. 2008 Aug;283(32):22177-85
    Zhuo Y et al
    2008/01/01
  • 備考:
    Species: Human, Application: Western Blot, Cell Lysates
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Cimmino F et al. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness. Oncogene 2009 May;28(19):2015-23
    Cimmino F et al
    2009/01/01
  • 備考:
    Application: IHC Paraffin-embedded,Western Blot, Sample Type: Cell Lysates,Whole Tissue
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gieseke F et al. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 2010 Nov;116(19):3770-9
    Gieseke F et al
    2010/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Zhao XY et al. Synergistic induction of galectin-1 by CCAAT/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells. J. Biol. Chem. 2011 Oct;286(42):36808-19
    Zhao XY et al
    2011/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Suzuki O et al. Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells. Lab. Invest. 2012 Feb;92(2):191-9
    Suzuki O et al
    2012/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ryu KH et al. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury. Exp. Cell Res. 2014 Aug;326(1):143-54
    Ryu KH et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Leskela S et al. Graves' disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells. PLoS ONE 2015;10(4):e0123938
    Leskela S et al
    2015/01/01
  • 備考:
    Application: Flow Cytometry,IHC Frozen, Sample Type: Whole Cells,Whole Tissue
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Yazawa EM et al. Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential. J. Invest. Dermatol. 2015 Jul;135(7):1849-62
    Yazawa EM et al
    2015/01/01
  • 備考:
    Application: Flow Cytometry,Western Blot, Sample Type: Tissue Homogenates,Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Unverdorben L et al. Prototype and Chimera-Type Galectins in Placentas with Spontaneous and Recurrent Miscarriages. Int J Mol Sci 2016 Apr;17(5)
    Unverdorben L et al
    2016/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Andersen MN et al. Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation. Onco Targets Ther 2017;10:1977-1982
    Andersen MN et al
    2017/01/01
  • 備考:
    Application: ELISA Capture, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Paz H et al. Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008. J. Exp. Clin. Cancer Res. 2018 Mar;37(1):67
    Paz H et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Flow
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Schulz H et al. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. Int J Mol Sci 2017 Jun;18(6)
    Schulz H et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Hirose I et al. Glucocorticoid receptor inhibits Müller glial galectin-1 expression via DUSP1-dependent and -independent deactivation of AP-1 signalling. J Cell Mol Med 2019 10;23(10):6785-6796
    Hirose I et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Chung LY et al. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res 2012 Aug;18(15):4037-47
    Chung LY et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed